请输入您要查询的百科知识:

 

词条 Safety monitoring
释义

  1. See also

  2. References

  3. External links

{{merge|Monitoring in clinical trials|date=November 2017}}

Safety monitoring of a clinical trial is conducted by an independent physician with relevant expertise. This is accomplished by review of adverse event, immediately after they occur, with timely follow-up through resolution.

Responsibility for data and safety monitoring depends on the phase of the study and may be conducted by sponsor or Contract research organization (CRO) staff or contractor, and/or by the Principal clinical investigator/project manager conducting the study. Regardless of the method used, monitoring must be performed on a regular basis. Oversight of the monitoring activity is the responsibility of the sponsor.

See also

  • Clinical monitoring
  • Data monitoring committee
  • European Medicines Agency
  • Serious adverse event (SAE)
  • U.S. Food and Drug Administration (FDA)

References

  • Ariel E. Quinio, Safety in Clinical Trials: Who is Responsible? International Biopharmaceutical Association:IBPA Publications, 2005
  • Carol Rados, Inside Clinical Trials Testing Medical Products in People FDA Consumer magazine, September–October 2003 Issue

External links

  • ClinicalTrials.gov from US National Library of Medicine
  • ICH Website
  • FDA Website
{{pharma-stub}}

3 : Clinical research|Medical monitoring|Pharmaceutical industry

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/11/15 18:10:39